-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Scinai Immunotherapeutics Ltd. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from 2021 to 2023.
- Scinai Immunotherapeutics Ltd. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$3.76M, a 26.1% decline year-over-year.
- Scinai Immunotherapeutics Ltd. annual Net Income (Loss) Attributable to Parent for 2023 was -$6.5M, a 12.1% decline from 2022.
- Scinai Immunotherapeutics Ltd. annual Net Income (Loss) Attributable to Parent for 2022 was -$5.8M, a 29.4% increase from 2021.
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)